Sionna Therapeutics, Inc.(SION:US)
Market Cap$175.69M
Key Metrics
Price$3.89
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$97.38M
EBITDA (TTM)-$107.69M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$63.32M
Total Assets$283.25M
Net Assets$265.78M
Total Debt$8.07M
Key Metrics
Price$3.89
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$97.38M
EBITDA (TTM)-$107.69M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$63.32M
Total Assets$283.25M
Net Assets$265.78M
Total Debt$8.07M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - |
| $31.84M | $29.11M | $25.04M | $23.29M | $21.43M | $19.23M | $18.13M | $28.74M | $12.78M | $12.6M | |
| Research and Development | $21.86M | $18.96M | $15.17M | $16.04M | $15.38M | $13.67M | $14.25M | $24.58M | $10.22M | $9.89M |
| Selling, General, and Administrative | $9.97M | $10.15M | $9.87M | $7.24M | $6.05M | $5.56M | $3.88M | $4.16M | $2.56M | $2.71M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$32.47M | -$29.6M | -$23.61M | -$23.81M | -$21.91M | -$19.66M | -$18.13M | -$27.98M | -$13.15M | -$12.6M |
| $2.58M | $2.82M | $3.17M | $3.53M | $3.84M | $3.18M | $2.29M | $2.54M | $1.3M | $719K | |
| Non-Operating Interest Income | $2.59M | $2.82M | $3.17M | $3.46M | $3.67M | $3M | $2.12M | $2.35M | $1.13M | $553K |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | -$3K | - | $0 | $71K | $171K | $177K | $166K | $190K | $168K | $166K |
Income Before Tax | -$29.89M | -$26.78M | -$20.44M | -$20.28M | -$18.07M | -$16.48M | -$15.85M | -$25.44M | -$11.85M | -$11.88M |
Income Tax | - | - | - | - | - | - | - | - | - | - |
Net Income | -$29.89M | -$26.78M | -$20.44M | -$20.28M | -$18.07M | -$16.48M | -$15.85M | -$25.44M | -$11.85M | -$11.88M |
Minority Interests | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$29.89M | -$26.78M | -$20.44M | -$20.28M | -$18.07M | -$16.48M | -$15.85M | -$25.44M | -$11.85M | -$11.88M |
Shares Outstanding (Basic) | 45.15M | 44.92M | 44.64M | 44.26M | 44.12M | 26.6M | 42.44M | - | 27.8M | - |
Shares Outstanding (Diluted) | 45.15M | 44.92M | 44.64M | 44.26M | 44.12M | 26.6M | 42.44M | - | 27.8M | - |
EPS (Basic) | -$0.66 | -$0.60 | -$0.46 | -$0.46 | -$0.41 | -$0.62 | -$0.37 | - | -$0.43 | - |
EPS (Diluted) | -$0.66 | -$0.60 | -$0.46 | -$0.46 | -$0.41 | -$0.62 | -$0.37 | - | -$0.43 | - |
EBIT | -$32.47M | -$29.6M | -$23.61M | -$23.81M | -$21.91M | -$19.66M | -$18.13M | -$27.98M | -$13.15M | -$12.6M |
EBITDA | -$31.84M | -$29.11M | -$23.46M | -$23.29M | -$21.43M | -$19.23M | -$17.97M | -$27.82M | -$12.78M | -$12.43M |